Cargando…

miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways

INTRODUCTION: Arteriosclerosis obliterans (ASO) is a disease that affects the lower extremities. The mechanism of ASO is associated with the proliferation and migration of vascular smooth muscle cells (VSMCs). miR-21 plays a key role in various biological processes of the cardiovascular system, asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shuichuan, Xu, Tuo, Huang, Xianying, Li, Siyi, Qin, Wenyi, Chen, Weijie, Zhang, Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855157/ https://www.ncbi.nlm.nih.gov/pubmed/31749878 http://dx.doi.org/10.5114/aoms.2018.78885

Ejemplares similares

MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin-2 in arteriosclerosis obliterans of the lower extremitie
por: Huang, Shuichuan, et al.
Publicado: (2018)

Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity
por: Hu, Min, et al.
Publicado: (2019)

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans
por: Yong, Jun, et al.
Publicado: (2019)

Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Xiao, Deshuang, et al.
Publicado: (2022)

HSPB1 Regulates Autophagy and Apoptosis in Vascular Smooth Muscle Cells in Arteriosclerosis Obliterans
por: Chen, Keqin, et al.
Publicado: (2022)

Expression and clinical significance of HSP27 and its phosphorylation in lower extremity arteriosclerosis obliterans
por: Bai, Junqing, et al.
Publicado: (2020)

Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Zhou, Ruhang, et al.
Publicado: (2021)

The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis
por: Yang, Bo, et al.
Publicado: (2023)

Retracted: Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans
por: Healthcare Engineering, Journal of
Publicado: (2023)

Predictive Value of Contrast-Enhanced Ultrasound in Chemical Lumbar Sympathectomy for End-Stage Arteriosclerosis Obliterans of the Lower Extremities
por: Wu, Yue, et al.
Publicado: (2022)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

Relationship between Angiotensin II, Vascular Endothelial Growth Factor, and Arteriosclerosis Obliterans
por: Liu, Yulian, et al.
Publicado: (2023)

Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
por: Yao, Wei, et al.
Publicado: (2020)

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report
por: Zhou, Bo, et al.
Publicado: (2020)

Increased Level of Tim-3(+)PD-1(+)CD4(+)T Cells With Altered Function Might Be Associated With Lower Extremity Arteriosclerosis Obliterans
por: Cui, Liyuan, et al.
Publicado: (2022)

Microarray Expression Profile and Bioinformatic Analysis of Circular RNA in Human Arteriosclerosis Obliterans
por: Zhou, Yu, et al.
Publicado: (2023)

Effect of Recombinant Netrin-1 Protein Combined with Peripheral Blood Mesenchymal Stem Cells on Angiogenesis in Rats with Arteriosclerosis Obliterans
por: Zeng, Jie, et al.
Publicado: (2022)

Loss of GRB2 associated binding protein 1 in arteriosclerosis obliterans promotes host autophagy
por: Ye, Meng, et al.
Publicado: (2021)

Application of E-coach chronic disease management model in rehabilitation management of patients with arteriosclerosis obliterans
por: Yuan, You-Yuan, et al.
Publicado: (2023)

Effects of Drug-Coated Balloon Therapy on CT Imaging Results and Levels of Vascular Inflammatory Cytokines in Patients with Arteriosclerosis Obliterans Lesions
por: Yang, Yanlin
Publicado: (2022)

Ameliorative effects of the traditional Chinese medicine formula Qing-Mai-Yin on arteriosclerosis obliterans in a rabbit model
por: Zhang, Lei, et al.
Publicado: (2020)

Neutrophil gelatinase-associated lipocalin as an early predictor of contrast-induced nephropathy following endovascular therapy for arteriosclerosis obliterans
por: Liu, Zhenjie, et al.
Publicado: (2020)

MicroRNA-30a-3p: a potential noncoding RNA target for the treatment of arteriosclerosis obliterans
por: Zhang, Mao, et al.
Publicado: (2023)

Inhibitory effect of PDGF-BB and serum-stimulated responses in vascular smooth muscle cell proliferation by hinokitiol via up-regulation of p21 and p53
por: Li, Jiun-Yi, et al.
Publicado: (2018)

Arteriosclerosis
Publicado: (1925)

Arteriosclerosis
Publicado: (1913)

Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4/NF-κB signaling pathway
por: Lou, Xinjiang, et al.
Publicado: (2019)

Sox9 mediates autophagy-dependent vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis
por: Yu, Qihong, et al.
Publicado: (2022)

TurboHawk plaque rotation system for treatment of arteriosclerosis occlusion in lower extremities: A pilot retrospective study
por: Yuan, Zhao, et al.
Publicado: (2021)

Qingjie Fuzheng granules inhibit colorectal cancer cell growth by the PI3K/AKT and ERK pathways
por: Yang, Hong, et al.
Publicado: (2019)

EXPERIMENTAL ARTERIOSCLEROSIS
por: Pearce, Richard M., et al.
Publicado: (1906)

The Biology of Arteriosclerosis
por: Pappenheimer, Alwin M.
Publicado: (1938)

The Treatment of Arteriosclerosis
Publicado: (1906)

Arteriosclerosis and Diabetes
Publicado: (1925)

Antisclerosin in Arteriosclerosis
por: Goldschmidt, S.
Publicado: (1904)

Athletics and Arteriosclerosis
Publicado: (1904)

Treatment of Arteriosclerosis
Publicado: (1907)

Test for Arteriosclerosis
Publicado: (1914)

Antisense long non-coding RNA WEE2-AS1 regulates human vascular endothelial cell viability via cell cycle G(2)/M transition in arteriosclerosis obliterans
por: Jiang, Baohong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oj0vuck7qrr0busu1073n991a1